Memory and trauma care refers to the field of psychology and therapy focused on addressing and healing the psychological wounds resulting from traumatic experiences. Trauma can profoundly affect an individual's memory, often leading to symptoms like flashbacks, nightmares, and intrusive thoughts. Memory itself can become fragmented or distorted as a result of traumatic events, making it difficult for individuals to process and make sense of their experiences. Effective trauma care involves a range of therapeutic approaches aimed at helping individuals cope with and heal from their trauma. This may include techniques such as cognitive-behavioral therapy (CBT), eye movement desensitization and reprocessing (EMDR), and narrative therapy. These approaches help individuals to process and reframe their memories, reducing the intensity of their emotional responses and enabling them to integrate their experiences into their broader life narratives in a healthier way. Furthermore, trauma care often emphasizes creating a safe and supportive environment for individuals to explore and express their feelings. This can involve building trust with a therapist or support group, developing coping strategies for managing distressing emotions, and fostering resilience in the face of adversity. Overall, memory and trauma care play a crucial role in helping individuals recover from traumatic experiences, enabling them to move forward with their lives in a more adaptive and empowered manner.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom